News
Customer Interview – Cambridge Epigenetix – Analytik Ltd
We had the opportunity to speak with Dr. Gary Yalloway and Dr. Julia Vivian, Senior Scientists at Cambridge Epigenetix on LM20 Microfluidizer®.
30 November 2022
News
News
5 Letter sequencing & tangible improvements to health care
CEGX CSO Joanna Holbrook recently appeared on Precision Medicine Forum Podcast
30 November 2022
News
CEGX presents sequencing technology at EACR Seville
Innovative Cancer Science ‘CEGX scientists discussed novel sequencing technology for early cancer detection’
30 June 2022
News
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human Health
3 June 2022
News
CEGX presents sequencing technology at Biology of Genomes 2022
CEGX scientists discussed novel technology at genomics conference in Cold Spring Harbour Laboratory
30 May 2022
News
2 March 2022
News
Cambridge Epigenetix Raises $88 Million Series D Financing to Advance Best-in-Class DNA Sequencing Technology Platform
CAMBRIDGE, United Kingdom, Nov. 02, 2021 — Cambridge Epigenetix (CEGX), a life sciences tools and technology company revolutionizing genome sequencing, today announced the signing of
3 November 2021
News
Guardian Epigenetics Article
Epigenetics, the misunderstood science that could shed new light on ageing
31 October 2021
News
Trinity in Japan Video Interview
Sir Shankar Balasubramanian, inventor of Next Generation DNA Sequencing (NGS)
31 October 2021
News
Article from Cancer Research UK Website
The award-winning researcher behind next generation sequencing (NGS)
30 October 2021
